Well, this made me sad:

From the FDA on the 17th of May:

FDA Approves New Treatment for Parkinson's Disease

The Food and Drug Administration today approved Azilect (rasagiline), a new molecular entity, for the treatment of Parkinson's disease. The drug is a monoamine oxidase type--B (MAO-B) inhibitor that blocks the breakdown of dopamine, a chemical that sends information to the parts of the brain that control movement and coordination.

"This is a welcome development for the more than 50,000 Americans who are each year diagnosed with Parkinson's disease, " said Dr. Steven Galson, Director of the Center for Drug Evaluation and Research. "Parkinson's is a relentless disease with limited treatment options, and each new therapy is an important addition to the physicians' treatment options."

We waited months and months for it to be approved--it was supposed to be on the market a year ago--before taking matters into our own hands. Ach.

Oops: should mention that I found this on BrainBlog.